Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
Med Vet Entomol ; 34(4): 440-451, 2020 12.
Article in English | MEDLINE | ID: mdl-32697402

ABSTRACT

The Phyllosoma complex is a Triatominae (Hemiptera: Reduviidae) group of medical importance involved in Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae) transmission. Most of the members of this group are endemic and sympatric species with distribution in Mexico and the southern U.S.A. We employed MaxEnt to construct ecological niche models of nine species of Triatominae to test three hypothesis: (a) whether species with a broad climatic niche breadth occupy a broader geographical range than species with a narrow climatic breadth, (b) whether species with broad distribution present high degree of climatic fragmentation/isolation, which was tested through landscape metrics; and (c) whether the species share the same climatic niche space (niche conservatism) considered through an equivalence test implemented in ENMtools. Overall, our results suggest that the geographical distribution of this complex is influenced mainly by temperature seasonality where all suitable areas are places of current and potential transmission of T. cruzi. Niche breadth in the Phyllosoma complex is associated with the geographical distribution range, and the geographical range affects the climatic connectivity. We found no strong evidence of niche climatic divergence in members of this complex. We discuss the epidemiological implications of these results.


Subject(s)
Chagas Disease/transmission , Climate , Triatominae , Animals , Ecosystem , Geography , Insect Vectors/parasitology , Mexico/epidemiology , Models, Biological , Seasons , Temperature , Triatominae/parasitology , Trypanosoma cruzi
2.
Med Vet Entomol ; 31(4): 392-401, 2017 12.
Article in English | MEDLINE | ID: mdl-28815634

ABSTRACT

The aims of the study were to (a) investigate the effect of trapping methods on alpha diversity; and (b) enhance the knowledge of the sandfly assemblage in the state of Quintana Roo. Field work was undertaken in a tropical forest of southern Mexico from August 2013 to July 2014. Sampling was conducted monthly during three consecutive nights. For each trapping night, 12 different types of trap were operated from 18.00 to 24.00 hours in four transects. Measures of alpha community diversity were based on the quantification of the number of species (Chao 2, Jackknife 2, Clench's equation, Margalef's index) and the community structure, as well as the dominance (Simpson and Berger-Parker indexes) and evenness (Shannon's entropy index, true diversity of the Jost and Pielou index). With a total sampling effort of 1728 night-traps, 16 101 phlebotomine sandflies were collected; they represented two genera and 13 species. Diversity estimates of 100% (Chao 2 and Clench's equation) and 85% (Jackknife 2) of potential species in the study area were calculated. Shannon traps and CDC light traps indicated the largest number of species, but only Shannon traps showed the greatest abundance. This inventory of sandflies is an important activity to enhance our knowledge of sandfly assemblages and guilds. The ultimate goal of studying alpha diversity in sandflies would be to have a better understanding of the population dynamics and all complex networks of interactions that may, in turn, be associated with the epidemiology of the disease.


Subject(s)
Biodiversity , Entomology/methods , Insect Control/methods , Psychodidae/classification , Animals , Mexico , Phlebotomus/classification , Population Dynamics
3.
Neuroscience ; 291: 118-27, 2015 Apr 16.
Article in English | MEDLINE | ID: mdl-25617656

ABSTRACT

In animal models, environmental enrichment (EE) has been found to be an efficient treatment for alleviating the consequences of neonatal hypoxia-ischemia (HI). However the potential for this therapeutic strategy and the mechanisms involved are not yet clear. The aim of present study is to investigate behavioral performance in the ox-maze test and Na+,K+-ATPase, catalase (CAT) and glutathione peroxidase (GPx) activities in the hippocampus of rats that suffered neonatal HI and were stimulated in an enriched environment. Seven-day-old rats were submitted to the HI procedure and divided into four groups: control maintained in standard environment (CTSE), control submitted to EE (CTEE), HI in standard environment (HISE) and HI in EE (HIEE). Animals were stimulated with EE for 9 weeks (1 h/day for 6 days/week) and then behavioral and biochemical parameters were evaluated. Present results indicate learning and memory in the ox-maze task were impaired in HI rats and this effect was recovered after EE. Hypoxic-ischemic event did not alter the Na+,K+-ATPase activity in the right hippocampus (ipsilateral to arterial occlusion). However, on the contralateral hemisphere, HI caused a decrease in this enzyme activity that was recovered by EE. The activities of GPx and CAT were not changed by HI in any group evaluated. In conclusion, EE was effective in recovering learning and memory impairment in the ox-maze task and Na+,K+-ATPase activity in the hippocampus caused by HI. The present data provide further support for the therapeutic potential of environmental stimulation after neonatal HI in rats.


Subject(s)
Environment , Hippocampus/enzymology , Hypoxia-Ischemia, Brain/therapy , Maze Learning/physiology , Memory Disorders/therapy , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Animals, Newborn , Catalase/metabolism , Disease Models, Animal , Glutathione Peroxidase/metabolism , Hypoxia-Ischemia, Brain/complications , Hypoxia-Ischemia, Brain/enzymology , Learning Disabilities/enzymology , Learning Disabilities/etiology , Learning Disabilities/therapy , Memory Disorders/enzymology , Memory Disorders/etiology , Random Allocation , Rats, Wistar , Treatment Outcome
4.
J Chemother ; 8(2): 122-9, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8708743

ABSTRACT

The aim of this multicentered, prospective and open study was to determine the clinical and bacteriological efficacy and safety of piperacillin/tazobactam (4g/500 mg IV tid) in the treatment of 79 adult patients with complicated urinary tract infections (UTI) requiring hospitalization. Forty-seven women and 32 men (mean age 54.2 years, and range 21-91) from 4 Argentinean and 6 Mexican hospitals were enrolled. Sixty-one clinically and bacteriologically evaluable patients were treated for a mean of 9.1 days (range 5-15). A favorable clinical response was seen in 83.6% and 80% at early and late assessment, respectively. Bacteriological eradication was achieved in 85.3% and 80% at early and late estimation, respectively. Escherichia coli was isolated in 33 cases, Klebsiella pneumoniae in 8, Enterococcus spp. in 7, Proteus mirabilis in 6, Pseudomonas aeruginosa in 3, Enterobacter spp. and Morganella morganii in 2. While 21% of all the clinical isolates were resistant to piperacillin, none of them was initially resistant to piperacillin/tazobactam. However, one female patient with a persistent UTI caused by E. coli developed resistance to piperacillin/tazobactam during treatment. A 64-year-old man with frontal meningioma developed purulent meningitis due to Enterobacter cloacae after neurosurgery. He was initially treated with ciprofloxacin, rifampin and amikacin and because of persistence of fever, he was moved to piperacillin/tazobactam. After 5 days of therapy, he developed coma secondary to intracranial hemorrhage and died. By then, the platelet count was normal (220,000/microliters), but the prothrombin time (19.5 seconds) and the partial thromboplastin time (63 seconds) were significantly prolonged. Our data suggest that piperacillin/tazobactam is a reliable therapy for complicated, non-complicated, community or hospital-acquired UTI.


Subject(s)
Drug Therapy, Combination/therapeutic use , Urinary Tract Infections/drug therapy , Adult , Aged , Aged, 80 and over , Drug Resistance, Microbial , Female , Humans , Male , Middle Aged , Penicillanic Acid/adverse effects , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/adverse effects , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Prospective Studies , Treatment Outcome
5.
J Chemother ; 6(3): 197-203, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7983503

ABSTRACT

The aim of this study was to determine the clinical and bacteriological efficacy and safety of piperacillin-tazobactam (PT) (4g/500 mg IV tid) in the treatment of 107 adult patients with lower respiratory tract infections (LRTI) requiring hospitalization. Patients included were 66 men and 41 women with a mean age of 55.2 years (range 18-89), enrolled from Mexican (6) and Argentinean (5) hospitals. Ninety-nine clinically evaluable patients (92.5%), 87 with pneumonia and 12 with bronchitis, were treated for a mean period of 9.3 and 7.3 days, respectively. Response to treatment was favorable in 94.3% cases with pneumonia and 100% of cases with bronchitis; 86 cases (80.3%) were bacteriologically evaluable, 77 with pneumonia (eradication 74, persistence 1, superinfection 2), and 9 with bronchitis (eradication in all). Streptococcus pneumoniae was recovered in 24, Klebsiella pneumoniae in 21, Staphylococcus aureus in 8, Haemophilus influenzae in 7, Pseudomonas aeruginosa in 5, Enterobacter spp. in 6, Escherichia coli in 6 and other organisms in 12. Toxicity or intolerance were not observed. Our data suggest that PT is a reliable therapy for severe LRTI.


Subject(s)
Drug Therapy, Combination/therapeutic use , Gram-Negative Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/drug therapy , Respiratory Tract Infections/drug therapy , Adolescent , Adult , Aged , Aged, 80 and over , Drug Administration Schedule , Drug Therapy, Combination/adverse effects , Female , Gram-Negative Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/microbiology , Humans , Male , Middle Aged , Penicillanic Acid/adverse effects , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/adverse effects , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Respiratory Tract Infections/microbiology
6.
Bol Med Hosp Infant Mex ; 47(8): 562-6, 1990 Aug.
Article in Spanish | MEDLINE | ID: mdl-2257094

ABSTRACT

The clinical charts belonging to patients suffering from congenital adrenal hyperplasia secondary to a deficiency of the enzyme 21-hydroxylase seen at the Endocrinology Department during 1978 to 1988 were reviewed. The 34 patients were analyzed for various clinical and biochemical parameters when admitted and during their follow-up. The reason for their consultation, in 73.5% of the cases was due to the presence of ambiguity in their genitalia at the time of their birth. The most frequent clinical variety was the classical or "salt-loser" in 55.8% of the cases. The growth chart analysis showed that those patients who were "salt-losers" grew and were categorized in lesser percentiles than those who had the simple variety of the disease. The results are similar to those reported in worldwide literature. A close follow-up with emphasis placed on clinical and laboratory data seems to allow for adequate growth and development of these patients.


Subject(s)
Adrenal Hyperplasia, Congenital , Adrenal Hyperplasia, Congenital/etiology , Adrenal Hyperplasia, Congenital/drug therapy , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male
7.
Bol Med Hosp Infant Mex ; 33(3): 495-506, 1976.
Article in Spanish | MEDLINE | ID: mdl-1275956

ABSTRACT

Considering the disparity of criteria regarding the use of sodium bicarbonate in the management of infants with diarrhea, dehydration and metabolic acidosis, a prospective study was done in 25 infants (13 managed without and 12 with bicarbonate) where it was demonstrated; a) The use of bicarbonate does not lead to a more rapid correction of the metabolic acidosis. b) Bicarbonate should not be used in patients with serum bicarbonate levels of 5 mEq/1. or over. c) Patients with dehydration and metabolic acidosis show hyperglycemia that returns to normal when the dehydration is corrected. This fact is of great interest because these children should not be considered nor managed as diabetics.


Subject(s)
Acidosis/drug therapy , Diarrhea, Infantile/drug therapy , Sodium/therapeutic use , Drug Evaluation , Humans , Infant
SELECTION OF CITATIONS
SEARCH DETAIL